CIK 0001158780
- Non-accelerated filer
- Smaller reporting company
Pluri Inc.
Sign in to watch- Ticker
- PLUR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 980351734
- Phone
- +972 747107171
- Business address
- MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
- 4 Open-market buy CEO & Chairman bought 15,000 shares at $2.80 ($42,000)
- 4 Open-market buy COO & President bought 10,000 shares at $2.85 ($28,500)
- 4 Open-market sale Director sold 43,215 shares at an average $3.12 ($134,793)
- 4 Open-market sale Director sold 67,858 shares at $4.02 ($272,789)
- 4 Open-market sale Director sold 45,000 shares at $4.00 ($180,000)
- 4 Open-market sale Director sold 35,000 shares at $4.02 ($140,840)
- 4 Grant or award CFO acquired 27,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 12,500 shares at an average $4.51 ($56,402)
- 4 Open-market sale Director sold 35,625 shares at an average $4.51 ($160,736)
- 4 Open-market sale CEO & Chairman sold 69,850 shares at an average $4.29 ($299,984)
- 4 Open-market sale CFO, Executive Vice President sold 69,850 shares at an average $4.29 ($299,984)
- 4 Open-market sale Director sold 26,453 shares at an average $4.29 ($113,546)
- 4 Open-market sale CFO, Executive Vice President sold 30,150 shares at $4.25 ($128,138)
- 4 Open-market sale CEO & Chairman sold 30,150 shares at $4.25 ($128,138)
- 4 Open-market sale Director sold 44,797 shares at an average $4.12 ($184,687)
- 4 Grant or award CEO & Chairman acquired 150,000 shares (grant or award)
- 4 Grant or award CFO, Executive Vice President acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
Page 9 of 18 · 352 filings